MRO & Manufacturing
Airbus Tests Exoskeletons to Boost Worker Safety and Efficiency
Airbus pilots industrial exoskeletons in global facilities to reduce physical strain by up to 40%, with plans to expand across aerospace manufacturing sites.
In the high-stakes world of aerospace manufacturing, precision, safety, and endurance are critical. Workers on final assembly lines perform physically demanding tasks that can lead to fatigue and musculoskeletal disorders (MSDs). To address these challenges, Airbus is testing industrial exoskeletons, wearable devices that support workers by reducing muscle strain and enhancing comfort. Once a sci-fi concept, exoskeletons are now being evaluated in Airbus facilities to protect workers and boost productivity.
Airbus’s pilot program is a data-driven, operator-focused initiative to integrate exoskeletons into manufacturing. With 118 units currently under evaluation in France, Spain, and Canada, and plans to expand to Germany, the UK, and the U.S., the program is setting a new standard for ergonomic innovation in aerospace.
Exoskeletons have progressed from bulky, powered devices in the early 2000s to lighter, passive systems today. Initially met with skepticism due to limited data and concerns about shifting pain points, their credibility has grown thanks to studies from organizations like INRS (France) and IRSST (Canada). These studies provide guidelines for safe deployment and highlight benefits like reduced muscle strain.
Airbus focuses on passive exoskeletons, which are mechanical, battery-free, and easier to integrate into workflows. These devices are lighter, more reliable, and cost-effective compared to powered exoskeletons. The pilot program tests their ability to relieve stress on shoulders, lumbar regions, and knees—areas most prone to strain in assembly line work.
Airbus’s medical team uses electromyography to measure muscle activity, alongside heart rate monitoring, to assess exoskeleton performance. In May 2025, a test showed a 10% to 40% reduction in shoulder and upper back muscular strain for paint shop operators sanding with exoskeletons. These operators, handling 2–3 kg sanders above their heads, reported less fatigue and discomfort.
Operators test exoskeletons for 2–3 months, performing tasks with and without the devices for comparison. Feedback is collected via questionnaires, ensuring the program remains operator-centric. According to Dr. Delphine Bouvet, who led the study, “These results confirm that an exoskeleton can in some cases provide support and comfort to the operator, all while reducing the arduousness of certain tasks such as sanding.”
“They confirm that an exoskeleton can in some cases provide support and comfort to the operator, all while reducing the arduousness of certain tasks such as sanding,” Dr. Delphine Bouvet, Airbus
Airbus tests exoskeletons tailored to specific tasks, such as sanding or fuselage assembly, focusing on support for shoulders, lumbar regions, or knees. This task-specific approach enhances effectiveness and user comfort. Use of exoskeletons is voluntary, considered a last resort when other ergonomic solutions—like task rotation or assistive devices—are insufficient, ensuring they complement existing workflows.
By involving operators in testing and feedback, Airbus refines the devices for better fit and usability, addressing issues like restricted movement or discomfort. This collaborative approach fosters acceptance and ensures the technology supports workers without disrupting production. Despite promising results, challenges remain. Some operators report discomfort from rigid frames or restricted mobility in tight spaces. The time needed to put on or remove exoskeletons (3–5 minutes) can also disrupt fast-paced assembly lines. Psychological barriers, such as perceptions of exoskeletons as “disability aids,” may lead to reluctance among some workers.
Airbus addresses these issues through a co-design approach, working with operators and ergonomists to improve device design and usability. Voluntary participation ensures exoskeletons are seen as supportive tools, not mandatory equipment, fostering greater acceptance.
Exoskeletons offer economic benefits by reducing injury-related costs, such as those from back or shoulder strain. Passive exoskeletons, with their lower cost and reliability, provide a viable solution for minimizing these expenses. As the manufacturing workforce ages—over 25% of EU manufacturing workers are over 50—exoskeletons could extend productive work life and reduce early retirement due to physical strain.
Airbus’s initiative could serve as a model for other industries, combining exoskeletons with other ergonomic tools like FlexTrack robots and zero-gravity arms to create safer, more efficient workplaces.
Airbus’s exoskeleton pilot program demonstrates how technology can enhance worker safety and efficiency. By focusing on passive, task-specific designs and prioritizing operator feedback, Airbus is pioneering ergonomic innovation in aerospace manufacturing. As the program expands and refines, it could drive broader adoption of exoskeletons, creating safer, more sustainable workplaces across industries.
What is an industrial exoskeleton? Are exoskeletons mandatory for Airbus workers? What types of tasks benefit most from exoskeleton use? How are exoskeletons tested at Airbus? What are the future plans for Airbus’s exoskeleton program?
Powering Production and Protecting People with Exoskeletons: Airbus’s Ergonomic Revolution
The Evolution of Industrial Exoskeletons
Scientific Backing and Ergonomic Benefits
Task-Specific Design and Voluntary Use
Challenges and the Road Ahead
Economic and Strategic Implications
Conclusion
FAQ
An industrial exoskeleton is a wearable device that supports specific body parts during physically demanding tasks, reducing muscle strain and preventing injuries.
No, Airbus’s exoskeleton program is voluntary, allowing operators to choose whether to use the devices for comfort and autonomy.
Tasks like sanding or fuselage assembly, involving repetitive overhead work or lifting, benefit most from exoskeleton support.
Each device is tested by a single operator for 2–3 months, with performance and physiological data collected and feedback gathered via questionnaires.
Airbus plans to expand testing to Germany, the UK, and the U.S., refining devices and planning for potential large-scale deployment.
Photo Credit: Airbus